Objective: This trial was conducted to evaluate the effectiveness of oral hypoglycemic agents on diabetic control and biochemical parameters of known diabetic subjects. Introduction: T2DM occurs due to abnormal metabolism of carbohydrates, proteins, and lipids leading to increased blood glucose characterized by polyuria and polydipsia due to relative5 deficiency or lack of insulin. Besides dietary control and insulin therapy, various oral hypoglycemic such as sulfonylurea biguanide, a thiazolidinedione, DPP-4 inhibitors, glucagon-like peptide inhibitors, and SGL2. Material and Methods: This comparative trial was carried out on previously diagnosed type-2 diabetic subjects. Nowshehra, and ICS, Peshawar in collaboration with KMC and PIMC Peshawar, Khyber Pakhtunkhwa, Pakistan. to Group A patients.